1. Mononuclear blood cell magnesium content and serum magnesium concentration in critically ill hypomagnesemic patients after replacement therapy
- Author
-
Phuong-Dung Lee, Ginger Ilardi, Roland N. Dickerson, Rex O. Brown, Syamal K. Bhattacharya, K. A. Kudsk, Gordon S. Sacks, and Christine A. Mowatt-Larssen
- Subjects
medicine.medical_specialty ,Pregnancy ,Nutrition and Dietetics ,Critically ill ,Magnesium ,ELECTROLYTE ABNORMALITY ,business.industry ,Endocrinology, Diabetes and Metabolism ,chemistry.chemical_element ,Mononuclear Blood Cell ,medicine.disease ,Gastroenterology ,Surgery ,Hypomagnesemia ,chemistry ,Magnesium deficiency (medicine) ,Internal medicine ,medicine ,Prospective cohort study ,business - Abstract
Magnesium (Mg) deficiency, commonly diagnosed as hypomagnesemia based upon low serum Mg concentrations, is a frequent electrolyte abnormality in critically ill patients. Intravenous replacement therapy is empiric and serum Mg concentrations have traditionally been used as guidelines for measuring efficacy. Recent studies have shown that the Mg content of mononuclear blood cells (MBCs) may provide a better index for Mg status than serum concentrations. The purpose of this study was to evaluate the effects of intravenous Mg replacement therapy on MBC Mg content and serum Mg concentrations in critically ill hypomagnesemic patients. Adult patients admitted to the trauma intensive-care unit (ICU) with serum Mg concentration 133 mumol/L), pregnancy, or those who were seropositive for HIV were excluded. Ten patients with moderate (> 0.4-0.6 mmol/L [> 1.0-1.5 mg/dL]) and severe ( 0.7). The doses of MgSO4 (0.5-0.75 mmol/kg) used in this study increased serum Mg concentrations, but did not result in a statistically significant change of MBC Mg content in this group of trauma ICU patients.
- Published
- 1997
- Full Text
- View/download PDF